Viagra: most recalled DTC brand in '06

Share this article:
News stories about Cox-2 drugs and ads for Viagra were the most recalled by consumers, according to a Verispan survey.

Pfizer's little blue pill was the most recalled among advertised brands in 2006, accounting for 14% of all product mentions in Verispan's Pharmaceutical Company Image 2006 survey. Lilly's Cialis was next, with 8% of mentions, followed by Pfizer's Lipitor and AstraZeneca's Nexium, both with 6%. Lunesta placed fifth, with 5.4% of mentions, and Ambien placed seventh, with 3.2% of mentions.

Viagra seems to have benefited from its sexy indication and powerful brand recognition. Nexium ranked first in DTC spending for 2005, according to Verispan's DTC Audit, while Viagra ranked 17th.

When it came to news stories recalled by respondents, Merck's Vioxx topped the list at 16% of product mentions, followed by Pfizer's Celebrex, at 8%. Insomnia leaders Lunesta and Ambien were new entrants at 3.4% and 3.1%, respectively. A quarter of respondents said drug ads prompted them to discuss treatment options with a physician.

The study, executed every two years, was drawn from more than 2,200 respondents.

Share this article:

Email Newsletters

More in News

Sanofi expands Gaucher disease portfolio

Sanofi expands Gaucher disease portfolio

The oral medication Cerdelga joins Cerezyme in its Fabry disease arsenal. Sanofi expects the drug will be priced "on par" with Cerezyme, which goes for around $300,000 a year in ...

Amicus seeks to upset Fabry market

Amicus seeks to upset Fabry market

Phase-III tests indicate patients may be able to switch from injectable enzyme-replacement therapies, like Fabrazyme, to the firm's oral drug.

Five things for pharma marketers to know: Wednesday, August 20

Five things for pharma marketers to know: Wednesday, ...

Novartis explores the virtual care space, a court has dismissed a lawsuit against IPAB, Doctors Without Borders calls the Ebola outbreak "a complete disaster" and Pfizer becomes the first pharma ...